pharmaphorum

DECEMBER 15, 2021

For their parts, patient advocates share survey results with drug companies or recruit patients and caregivers to speak about the nature of their diseases and existing treatments. Second—and closely related to the first transformation—patient centricity requires new kinds of relationships between industry and patient advocacy groups.

Pharma Companies 145

Pharma Companies Development Medicine Clinical Trials 145

Placebo Control

MAY 30, 2013

Even by the already-painfully-embarrassingly-low standards of clinical trial enrollment in general, patient enrollment in cancer clinical trials is slow. In many cancer trials, randomizing one patient every three or four months isn't bad at all – in fact, it's par for the course. Horribly slow.

Clinical Trials 40

Clinical Trials Clinical Trials Trials Pharma Companies 40

Cloudbyz

SEPTEMBER 25, 2020

Using our StartUs Insights Platform , covering 1.116.000+ startups & emerging companies, we looked at innovation in the field of pharma. For this research, we identified 164 relevant solutions and picked 5 to showcase below. Clinical trials play a pivotal role in drug development. Embleema – Patient Advocacy.

Pharma Companies 52

Pharma Companies Big Data Drugs Clinical Trials 52

pharmaphorum

DECEMBER 21, 2020

It’s a revolutionary approach that allowed the vaccine to be made within a few days of the SARS-CoV-2 genetic code becoming available – what’s taken months are the rigorous clinical trials that proved the vaccines were safe and effective. They are very good doctors, scientists and entrepreneurs.

Vaccination 111

Vaccination Vaccine Doctors Doctor 111

pharmaphorum

SEPTEMBER 28, 2020

Clinical trial readouts continue to emerge despite countries’ lockdown policies, providing several decision-making challenges for healthcare professionals such as haematologists and oncologists – also known as haem/oncs. Challenges for community-based haem/oncs.

Doctors 105

Doctors Doctor Pharma Companies Clinical Trials 105

pharmaphorum

APRIL 8, 2021

COVID-19 has been a trial-by-fire showing just how quickly drugs and vaccines can be developed under the right circumstances – but there is much to do to ensure this progress is not lost, said speakers at WIRED Health 2021, including the CEOs of BioNTech and BenevolentAI. . Data is the lifeblood of AI-powered research.

Development 93

Development Drugs Vaccination Vaccine 93

The Pharma Data

NOVEMBER 27, 2020

This week, another pharma company revealed a new technology device that can detect if a patient is infectious or not, while the Russian government published results of its Sputnik V vaccine, claiming it is more than 95 per cent efficient 42 days after the first dose.

Vaccination 52

Vaccination Vaccine Immune Response Marketing 52

Pharma Marketing Network

JUNE 8, 2020

Working in both marketing and advertising campaigns but also market research, strategic planning, workshop facilitation. So when Bob and I got together, it was this “how can we service clinics” but also how can we help patients find the clinics that have the medical answers that they’re looking for. Bob (83Bar): Yes, we do.

Doctors 40

Doctors Doctor Clinical Trials Clinical Trials 40

pharmaphorum

APRIL 1, 2021

In the past couple of years, Turbine worked with a number of big pharma companies, including Bayer, and has also started building its own pipeline, including a target delivering new biological insight in PARP inhibitor resistance. “We There’s not really a well-developed ecosystem of biotech funding and spin-out companies.

Bioinformatics 123

Bioinformatics Drugs Development Scientist 123

pharmaphorum

JANUARY 29, 2021

This has, of course, garnered immense excitement – Doctors Emmanuelle Charpentier and Jennifer Doudna were named winners of the Nobel Prize for chemistry in recognition of their discovery of CRISPR/Cas9 gene editing technology. Since Macrae joined the company just four years ago, Sangamo has more than tripled its staff and raised $1.6

Gene Editing 145

Gene Editing Gene Gene Therapy In-Vivo 145

pharmaphorum

AUGUST 1, 2022

In Kenya, the government did research a few years back and found that their public primary care facilities, on average, met less than half of the standards in terms of staffing, quality management, and more. The platform brings in clinical expertise and allows different stakeholders to work together, including the patient.

Development 78

Development Pharma Companies Drugs Life Science 78

Drug Discovery World

AUGUST 16, 2022

These observations may come to light in the clinic, but these disparities can be attributed to every phase of the drug development pipeline – clinical trials, translational research and, ultimately, drug discovery. . Results from clinical studies with poor representation may not apply to the general population.

Research 52

Research Clinical Trials Clinical Trials Trials 52

pharmaphorum

MARCH 12, 2021

COVID-19 has transformed the way we think about patient participation in trial design – but there are still many barriers to overcome in improving engagement. Speakers at the NIHR’s recent virtual event for the pharma industry discussed best practices for bringing patient insights into research.

Trials 132

Trials Research Pharma Companies Clinical Trials 132

Pharmaceutical Technology

MARCH 17, 2023

This is partly due to the differing business models used by pharma companies and digital therapeutic developers. According to Anguera, the field is in its infancy, particularly when it comes to testing approaches in clinical trials. Securing reimbursement for digital therapeutics also continues to impede its uptake.

Production 278

Production Development Pharma Companies Marketing 278

World of DTC Marketing

MAY 24, 2021

Despite advances in diagnosis and treatment, doctors still have much to learn about what triggers a cell to become cancerous and why some people who have cancer do better than others. A pharma company could spend billions developing a treatment while a product that allows people to live with cancer for decades seems elusive.

Drugs 193

Drugs Vaccination Vaccine Pharma Companies 193

XTalks

OCTOBER 1, 2020

WeiQi Lin, MD, PhD, executive vice president of research & development and principal scientist, DURECT Corporation. Lin has made several transitions throughout her career, from being a clinician at an academic center, to academic research, to heading business development in industry. Motivations for Transition. Key Moments.

Scientist 52

Scientist In-Vitro Research Life Science 52

pharmaphorum

AUGUST 23, 2022

With no specific medication available, doctors are likely to recommend exercise and self-management of the condition, through rest and reduced workload. Research into coronaviruses has been happening for decades, and this facilitated the development of the vaccines against COVID-19. Next steps.

Vaccination 134

Vaccination Vaccine Development Trials 134

World of DTC Marketing

JUNE 22, 2021

(New York Times ) If you spend any time reading pharma PR releases, you’ll see over and over again corporate managements stressing the importance of the shareholder. When a new drug is derailed the first thing that pops out is the effect on the company’s stock price, not patients.

Drugs 156

Drugs Pharma Companies Medicine Doctors 156

pharmaphorum

JULY 9, 2021

Digital technologies are proving their value by allowing for better care, improved adherence and a more connected ecosystem between doctors, patients and pharma. Patients can answer questionnaires to provide PROMs, and the app links up with a clinical platform that the care team uses to understand what’s going on,” Parkes explains.

Doctors 69

Doctors Doctor Marketing Development 69

The Pharma Data

NOVEMBER 16, 2020

The “polypill” containing three generic blood pressure medications and a statin dramatically reduced the risk of heart-related illness in people with no prior history of heart problems, according to clinical trial results. The polypill/aspirin combination reduced heart problems and deaths by 31%, the researchers discovered.

Doctors 52

Doctors Doctor Cardiology Pharma Companies 52